{"id":2310,"date":"2025-10-13T13:25:54","date_gmt":"2025-10-13T13:25:54","guid":{"rendered":"https:\/\/www.iforbes.cz\/?p=2310"},"modified":"2025-10-13T13:25:54","modified_gmt":"2025-10-13T13:25:54","slug":"astrazeneca-meni-americkou-burzu-co-to-znamena-pro-evropskeho-investora","status":"publish","type":"post","link":"https:\/\/www.iforbes.cz\/index.php\/2025\/10\/13\/astrazeneca-meni-americkou-burzu-co-to-znamena-pro-evropskeho-investora\/","title":{"rendered":"AstraZeneca m\u011bn\u00ed americkou burzu. Co to znamen\u00e1 pro evropsk\u00e9ho investora?"},"content":{"rendered":"\n<p><strong>Na za\u010d\u00e1tku t\u00fddne se cena akci\u00ed farmaceutick\u00e9ho giganta AstraZenecy na Lond\u00fdnsk\u00e9 burze zv\u00fd\u0161ila o 1,5 %*. D\u016fvod? \u0160lo o reakci na pl\u00e1novan\u00fd p\u0159esun obchodov\u00e1n\u00ed z burzy Nasdaq prost\u0159ednictv\u00edm americk\u00fdch depozitn\u00edch certifik\u00e1t\u016f p\u0159\u00edmo na New York Stock Exchange (NYSE). V n\u00e1vaznosti na to investo\u0159i v Evrop\u011b za\u010dali uva\u017eovat: \u201eCo by takov\u00fd krok znamenal pro m\u00e9 portfolio?\u201c<\/strong><\/p>\n\n\n\n<p><strong>Harmonizace<\/strong><\/p>\n\n\n\n<p>P\u0159edseda p\u0159edstavenstva Michel Demare v ofici\u00e1ln\u00edm prohl\u00e1\u0161en\u00ed zd\u016fraznil, \u017ee nov\u00fd harmonizovan\u00fd model kotov\u00e1n\u00ed m\u00e1 podpo\u0159it p\u0159edev\u0161\u00edm dlouhodobou strategii udr\u017eiteln\u00e9ho r\u016fstu a p\u0159\u00edstup ke glob\u00e1ln\u00edm investor\u016fm. Z prohl\u00e1\u0161en\u00ed d\u00e1le vypl\u00fdv\u00e1, \u017ee AstraZeneca z\u016fst\u00e1v\u00e1 i nad\u00e1le pevn\u011b ukotvena ve Velk\u00e9 Brit\u00e1nii \u2013 se s\u00eddlem, da\u0148ovou rezidenc\u00ed a prim\u00e1rn\u00edmi burzovn\u00edmi z\u00e1pisy v Lond\u00fdn\u011b a Stockholmu. Je tedy mo\u017en\u00e9 konstatovat, \u017ee p\u0159esun v r\u00e1mci Spojen\u00fdch st\u00e1t\u016f neznamen\u00e1 \u00fanik z Lond\u00fdna, ale sp\u00ed\u0161e snahu spole\u010dnosti o roz\u0161\u00ed\u0159en\u00ed mezin\u00e1rodn\u00ed investi\u010dn\u00ed z\u00e1kladny.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><img loading=\"lazy\" width=\"605\" height=\"419\" src=\"https:\/\/www.iforbes.cz\/wp-content\/uploads\/2025\/10\/image-2.png\" alt=\"\" class=\"wp-image-2311\" srcset=\"https:\/\/www.iforbes.cz\/wp-content\/uploads\/2025\/10\/image-2.png 605w, https:\/\/www.iforbes.cz\/wp-content\/uploads\/2025\/10\/image-2-300x208.png 300w, https:\/\/www.iforbes.cz\/wp-content\/uploads\/2025\/10\/image-2-392x272.png 392w, https:\/\/www.iforbes.cz\/wp-content\/uploads\/2025\/10\/image-2-130x90.png 130w, https:\/\/www.iforbes.cz\/wp-content\/uploads\/2025\/10\/image-2-600x417.png 600w\" sizes=\"(max-width: 605px) 100vw, 605px\" \/><figcaption>V\u00fdkonnost akci\u00ed AstraZeneca za posledn\u00edch p\u011bt let. * Zdroj: Trading Economics<\/figcaption><\/figure><\/div>\n\n\n\n<p><strong>Lond\u00fdn pod tlakem<\/strong><\/p>\n\n\n\n<p>Kroky velk\u00fdch firem v\u0161ak evokuj\u00ed \u0161ir\u0161\u00ed trend. Lond\u00fdn v posledn\u00edch letech \u010del\u00ed v\u00fdrazn\u00e9mu odlivu presti\u017en\u00edch jmen \u2013 Unilever p\u0159esunul sv\u00e9 aktivity do Amsterdamu, p\u0159i\u010dem\u017e Glencore a Ashtead uva\u017euj\u00ed o podobn\u00fdch kroc\u00edch. Pr\u00e1v\u011b proto se zpr\u00e1vy o mo\u017en\u00e9m odchodu AstraZenecy z Lond\u00fdna vn\u00edmaly sp\u00ed\u0161e s obavami. Tyto obavy jsou ale na z\u00e1klad\u011b aktu\u00e1ln\u00edch informac\u00ed \u010d\u00e1ste\u010dn\u011b rozpt\u00fdlen\u00e9, z\u00e1rove\u0148 se v\u0161ak ukazuje, \u017ee konkurence mezi burzami je tvrd\u0161\u00ed ne\u017e kdykoli p\u0159edt\u00edm.<\/p>\n\n\n\n<p><strong>Politick\u00fd rozm\u011br<\/strong><\/p>\n\n\n\n<p>Nezanedbateln\u00fd je tradi\u010dn\u011b i politick\u00fd tlak ze strany USA. Prezident Donald Trump opakovan\u011b varoval farmaceutick\u00e9 firmy, \u017ee pokud nezv\u00fd\u0161\u00ed investice a v\u00fdrobu v USA, mohou \u010delit vysok\u00fdm cl\u016fm. P\u0159esun obchodov\u00e1n\u00ed na NYSE proto m\u016f\u017ee b\u00fdt vn\u00edm\u00e1n i jako diplomatick\u00e9 gesto \u2013 zp\u016fsob, jak z\u016fstat bl\u00ed\u017ee k americk\u00fdm investor\u016fm a regula\u010dn\u00edm org\u00e1n\u016fm, ani\u017e by firma ztratila svou evropskou identitu.<\/p>\n\n\n\n<p>Krom\u011b toho se firma za\u010d\u00e1tkem z\u00e1\u0159\u00ed rozhodla zru\u0161it pl\u00e1novan\u00e9 roz\u0161\u00ed\u0159en\u00ed v\u00fdzkumn\u00e9ho centra v Cambridge v hodnot\u011b 200 milion\u016f GBP, co\u017e na druh\u00e9 stran\u011b signalizuje, \u017ee ani ve Velk\u00e9 Brit\u00e1nii nen\u00ed podnikatelsk\u00e9 prost\u0159ed\u00ed bez probl\u00e9m\u016f.<\/p>\n\n\n\n<p><strong>Co bude d\u00e1l?<\/strong><\/p>\n\n\n\n<p>Z pohledu evropsk\u00e9ho investora je p\u0159esun AstraZenecy na NYSE p\u0159edev\u0161\u00edm o praktick\u00fdch d\u016fsledc\u00edch. Roz\u0161\u00ed\u0159en\u00ed p\u0159\u00edstupu k americk\u00e9mu kapit\u00e1lu m\u016f\u017ee podpo\u0159it dlouhodob\u00fd r\u016fst spole\u010dnosti, co\u017e se m\u016f\u017ee projevit i na v\u00fdkonu akci\u00ed na lond\u00fdnsk\u00e9 burze. Z\u00e1rove\u0148 v\u0161ak tento krok p\u0159ipom\u00edn\u00e1, \u017ee Lond\u00fdn u\u017e nen\u00ed samoz\u0159ejm\u00fdm centrem pro glob\u00e1ln\u00ed firmy a tlak konkurence z USA \u010di EU bude \u010dasem nar\u016fstat.<\/p>\n\n\n\n<p><strong>David Matulay, analytik <\/strong><a rel=\"noreferrer noopener\" href=\"https:\/\/investingfox.com\/cs\" target=\"_blank\"><strong>InvestingFox<\/strong><\/a><\/p>\n\n\n\n<p><em>Foto: AdobeStock<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Na za\u010d\u00e1tku t\u00fddne se cena akci\u00ed farmaceutick\u00e9ho giganta AstraZenecy na Lond\u00fdnsk\u00e9 burze zv\u00fd\u0161ila o 1,5 %*. D\u016fvod? \u0160lo o reakci<\/p>\n","protected":false},"author":1,"featured_media":2312,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_container_layout":"default_layout","colormag_page_sidebar_layout":"default_layout"},"categories":[58],"tags":[350,362,361,190,268],"_links":{"self":[{"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/posts\/2310"}],"collection":[{"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/comments?post=2310"}],"version-history":[{"count":1,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/posts\/2310\/revisions"}],"predecessor-version":[{"id":2313,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/posts\/2310\/revisions\/2313"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/media\/2312"}],"wp:attachment":[{"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/media?parent=2310"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/categories?post=2310"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.iforbes.cz\/index.php\/wp-json\/wp\/v2\/tags?post=2310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}